Vanberra Signal

Insilab

Curated by Signal

Tool for prediction of protein binding sites and protein-ligand interactions

Overview

Insilab develops tools for drug discovery. ProBis tools support prediction of protein binding sites and protein-ligand interactions. These algorithms search for local similarities in physico-­chemical properties in different protein surface structures independently of sequence or fold. The proteins are modeled as protein graphs, i.e., rigid 3D objects, consisting of vertices and edges. The algorithms can be used for prediction of protein binding sites and ligand transposition in PDB protein structures. LiSiCA (Ligand Similarity using Clique Algorithm) is a ligand-based virtual screening software that searches for 2D and 3D similarities between a reference compound and a database of target compounds. The similarities are expressed using the Tanimoto coefficients and the target compounds are ranked accordingly. MaxCliqueDyn is an algorithm for finding a maximum clique in an undirected graph. The company also collaborates with experimental laboratories and pharmaceutical companies and performs experiments in silico.

Key facts

Founded
2016

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online shop for the purchase of fitness equipment and accessories

    Health TechnologyZalec, Slovenia
  • Provider of uroflowmetry devices to help individuals to monitor urinary health

    Health TechnologyCelje, Slovenia
  • Decentralized medical data storage solution for medical records

    Health TechnologyKranj, Slovenia

About Insilab

What does Insilab do?

Insilab develops tools for drug discovery.

Where is Insilab headquartered?

Insilab is headquartered in Ljubljana, Slovenia.

When was Insilab founded?

Insilab was founded in 2016.

Which sector is Insilab in?

Insilab operates in Health Technology.

Who are Insilab's competitors?

Companies similar to Insilab include Olumpus-shop, iPeeWell, and Iryo Network.